2007
DOI: 10.1097/01.nrl.0000254706.85609.95
|View full text |Cite
|
Sign up to set email alerts
|

Lymphomatosis Cerebri Presenting as Rapidly Progressive Dementia

Abstract: This case is notable in that it presents a patient with progressive dementia whose diagnosis of primary central nervous system lymphoma (PCNSL) was delayed because of the lymphoma's atypical diffusely infiltrating nature. Awareness of this unique presentation may hasten the time between clinical presentation, diagnosis, and subsequent treatment.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

1
19
0

Year Published

2007
2007
2016
2016

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 30 publications
(20 citation statements)
references
References 18 publications
(13 reference statements)
1
19
0
Order By: Relevance
“…Two infiltration patterns of lymphoma cells have been reported: diffuse scattered infiltration, 3,9,15 and both perivascular proliferation and diffuse scattered infiltration. 6,7,10,11,13,14 Most cases of LC were diagnosed as DLBL. 3,[6][7][8][9][10][11][12][13]15 In this case, the cerebral white matter lesion mimicking diffuse leukoencephalopathy resembled typical LC.…”
Section: Discussionmentioning
confidence: 99%
“…Two infiltration patterns of lymphoma cells have been reported: diffuse scattered infiltration, 3,9,15 and both perivascular proliferation and diffuse scattered infiltration. 6,7,10,11,13,14 Most cases of LC were diagnosed as DLBL. 3,[6][7][8][9][10][11][12][13]15 In this case, the cerebral white matter lesion mimicking diffuse leukoencephalopathy resembled typical LC.…”
Section: Discussionmentioning
confidence: 99%
“…Lymphomatosis cerebri (LC), an atypical rare form of PCNSL, presents as a diffuse infiltration without the formation of a mass lesion (2). Its appearance on brain MRI is characterized by diffuse leukoencephalopathy, making LC difficult to distinguish from white matter disorders such as infection, inflammation and vascular and toxic diseases (3)(4)(5)(6)(7).…”
Section: Introductionmentioning
confidence: 99%
“…Although comprehensive therapy improves progression-free and overall survival (OS) rates compared with untreated patients, the 5-year survival rate of patients that receive treatment remains 20-25% (29). In addition, 35-60% of patients experience ectopic recurrence within two years of diagnosis.…”
Section: Discussionmentioning
confidence: 99%